This prediction is based on results of the national prevention programmes but the affirmation will become reality nationally within 20 years. It is predicted to be classified as a “rare cancer” in Australia by 2022, when it should drop to less than six cases per 100,000 people. In 2007, Australia became one of the first countries to introduce a Human Papilloma Virus (HPV) vaccination scheme for girls. The programme was later extended to boys. The national screening programme began in 1991. Cervical cancer is the fourth-most frequent cancer in women and has a high mortality rate globally, according to the World Health Organization (WHO).
About nine in 10 deaths from cervical cancer happen in low and middle-income countries. It is caused by “high-risk” types of HPV, a sexually transmitted infection. Last year, Australia replaced its routine screening standards for the cancer , a pap smear examination , with more sensitive HPV cervical screening tests.In fact, there are more than 100 types of HPV. In the vast majority of cases, there will be no symptoms and the infection will clear on its own, but in some cases persistent infection can lead to cervical disease. Some lower risk HPV types can lead to genital warts.The HPV vaccine protects against four types of HPV which cause around 80% of cervical cancer.